-
Research/Project Funding Opportunity
-
Posted 1 year ago
Notice of Termination of PAR-22-111- Early-Stage Preclinical Validation of Therapeutic Leads for Diseases of Interest to the NIDDK (R01 Clinical Trial Not Allowed)
at
National Institutes of Health
in
United States
0
0
National Institutes of Health
